How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

A phase 1/1b Study of the Theranostic Pair RYZ811 (diagnostic) And RYZ801 (therapeutic) In Patients With Glypican-3-positive (gpc3+) Previously Treated, Unresectable Hepatocellular Carcinoma

calendar_today February 20, 2026 person webmaster domain rayzebio

The post A phase 1/1b Study of the Theranostic Pair RYZ811 (diagnostic) And RYZ801 (therapeutic) In Patients With Glypican-3-positive (gpc3+) Previously Treated, Unresectable Hepatocellular Carcinoma appeared first on RayzeBio .

open_in_new Read original post